Urology

Urology
Audio Summaries

The literature in urology doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

9 active journals1,923 audio summaries

Recent summaries

The latest articles summarized from urology journals.

Clinical Uses of Common Genetic Variants Associated with Common Diseases

The New England journal of medicine|Sep 23, 2026

The authors investigate why the integration of polygenic risk scores and genomic knowledge into clinical practice for common adult-onset diseases has been slow, despite advancements in genomics and the identification of numerous genetic variants associated with these conditions. They explore potential applications of these scores and pharmacogenomics in improving prevention and treatment strategies as genome sequencing becomes more accessible.

Surgical Strategies for Apical Pelvic Organ Prolapse: A Systematic Review and Network Meta-Analysis

International urogynecology journal|Sep 23, 2026

The authors aimed to compare the effectiveness and safety of various surgical treatments for primary apical pelvic organ prolapse (POP) through a systematic review and network meta-analysis of randomized controlled trials. They found that mesh-augmented surgical approaches, including vaginal, laparoscopic, and abdominal repairs, significantly reduced anatomical recurrence compared to native tissue repair, although these methods were associated with higher risks of mesh-related complications. Notably, sacrocolpopexy demonstrated favorable anatomical durability with fewer recurrence-related reoperations.

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

The New England journal of medicine|Sep 23, 2026

This phase 1 study investigates the safety and efficacy of anitocabtagene autoleucel (anito-cel), a BCMA-directed CAR T-cell therapy, in patients with relapsed or refractory multiple myeloma who have undergone multiple prior treatments. The results indicate a high response rate (100%) with a significant proportion achieving complete response (79%), while adverse events, particularly cytokine release syndrome and neurotoxicity, were mostly mild. The findings suggest that anito-cel may be a promising treatment option for this challenging patient population.

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome

The New England journal of medicine|Sep 23, 2026

This study investigates the efficacy and safety of etuvetidigene autotemcel (etu-cel), an autologous gene therapy, for treating Wiskott-Aldrich syndrome, a rare genetic disorder. The results indicate a high overall survival rate of 96% at both 1 and 5 years post-treatment, along with a significant reduction in severe infections and bleeding events after therapy. The findings suggest that etu-cel provides a sustained clinical benefit for patients with this condition.

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

The New England journal of medicine|Sep 23, 2026

The authors aimed to determine whether screening with a multicancer early-detection test, in addition to usual care, reduces the incidence of late-stage cancers (stage III or IV) compared to usual care alone. In a randomized controlled trial involving over 142,000 participants, they found no significant difference in the incidence rates of stage III or IV cancers between the two groups after three screening rounds. While there was a trend towards a lower incidence of stage IV cancers, the results were not conclusive, indicating the need for further follow-up.

Comparison of Postoperative Functional Recovery and Anatomical Restoration in Patients with Pelvic Organ Prolapse Undergoing Three Types of Apical Suspension Techniques: A Retrospective Study

International urogynecology journal|Sep 23, 2026

This study aimed to compare the effects of three surgical techniques—sacrospinous ligament fixation (SSLF), laparoscopic lateral suspension (LLS), and extraperitoneal high uterosacral ligament suspension (EHUS)—on anatomical restoration and functional recovery in patients with pelvic organ prolapse (POP). The findings indicated that while all techniques had similar surgical success rates, SSLF showed superior anatomical outcomes and greater symptom improvement compared to EHUS at 12 months postoperatively.

The Surgical Challenge of the Repeat Sacrocolpopexy

International urogynecology journal|Sep 23, 2026

The authors aimed to address the lack of clear guidelines for surgical retreatment following the failure of sacrocolpopexy (SCP), the standard procedure for pelvic organ prolapse repair. They reviewed literature on repeat SCP, finding that laparoscopic sacrocolpopexy was the most common reoperation technique, with high short-term success rates and low reoperation rates. The study highlights the need for further research with longer follow-up to better understand the management of SCP failures.

Alpha-Linolenic Acid and Tarantula Cubensis Extract Attenuate Bladder Inflammation in Cyclophosphamide-Induced Cystitis: A Comparative Experimental Study

International urogynecology journal|Sep 23, 2026

The authors aimed to determine whether alpha-linolenic acid (ALA) and Tarantula cubensis extract (TCAE) provide greater protection against bladder inflammation than the current intravesical therapy, hyaluronic acid (HA), in a cyclophosphamide-induced cystitis model. Their findings indicate that both ALA and TCAE effectively reduced bladder injury, with ALA showing the most significant histological and antioxidative benefits. This suggests ALA as a promising candidate for further therapeutic exploration in treating bladder inflammation.

Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial

JAMA|Sep 23, 2026

The study aimed to determine whether intravenous tenecteplase administered before endovascular thrombectomy (EVT) improves outcomes in patients with moderate to severe basilar artery occlusion presenting 4.5 to 24 hours after stroke onset. The findings revealed no significant difference in functional independence or safety outcomes between the tenecteplase plus EVT group and the EVT alone group, suggesting that the addition of tenecteplase does not enhance recovery in this patient population.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead

Lancet (London, England)|Sep 22, 2026

This paper aims to address the adverse impacts of peripheral arterial disease (PAD) and the disparities in outcomes among affected populations. The authors highlight the significant individual and societal burdens of PAD, particularly on underserved groups, and propose both short-term and long-term strategies to improve management and access to care, including enhanced awareness and multidisciplinary treatment approaches. The study emphasizes the need for targeted interventions to reduce the prevalence and consequences of PAD, especially in vulnerable communities.

Start listening to urology research

14-day free trial. Pick your journals and go.